Orcerin GM Tablet is a combination pharmaceutical formulation containing Glucosamine sulfate (750 mg), Diacerein (50 mg), and Methyl Sulfonyl Methane (MSM) (250 mg), designed to support joint health and manage symptoms associated with osteoarthritis and other degenerative joint disorders. Glucosamine is an amino sugar that plays a crucial role in the synthesis of glycosaminoglycans and proteoglycans, essential components of cartilage matrix, thereby promoting cartilage repair and maintenance. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and chondroprotective properties by inhibiting interleukin-1 beta, a key mediator in cartilage degradation and inflammation. MSM is an organic sulfur compound that contributes to the reduction of oxidative stress and inflammation, enhancing joint flexibility and alleviating pain. The synergistic action of these three active ingredients helps reduce joint pain, swelling, and stiffness while improving mobility and overall joint function. Orcerin GM Tablet is typically prescribed as part of a comprehensive treatment plan for patients with mild to moderate osteoarthritis and other joint-related conditions. It is advisable to use this medication under medical supervision, considering potential contraindications and interactions with other therapies. Regular monitoring and adherence to prescribed dosage ensure optimal therapeutic outcomes and improved quality of life for patients with joint disorders.